Management Team
Gary H. Stroy- President & CEO
Mr. Stroy is a pharmaceutical and medical device executive/entrepreneur. From 1969 to
2004 he was a senior manager at four large pharmaceutical firms (GSK, Baxter, Syntex and Bayer), a founder of seven venture-backed
medical device companies (Sicca Labs, LifeScan, Biotrack, ChemTrak, Aprise, Abaxis and LXN), an angel investor, venture partner
or general partner with several first-tier West Coast venture capital firms (Sequoia Capital, USVP, Delphi Ventures, MedVenture
Associates and Walden International) and a board member at several drug and device firms (RxKinetix, Cutera, Avocet, NeurogesX,
Coalescent Surgical, Accumetrics and Carbylan Biosurgery). Since 2005, Mr. Stroy has specialized in funding,
restructuring or merging startup companies including: Afmedica, that he sold to Angiotech Pharmaceuticals four months after
joining the company, Neuralieve, where put together a lean management team to complete both a product and clinical development
program in 18 months, and IntelliDx, where he salvaged a badly managed product development program but then had to close the
company when two of the firm’s key investors pulled their support in the 2008/2009 financial meltdown. Mr. Stroy earned an MS in Industrial Pharmacy (double major in Pharmacology
and Business) from the University of Nebraska, a BS degree in Chemistry from Colorado State University and a Certificate in International Business from UCLA. He has been a featured
speaker at several medical meetings on topics in both science and business and is recognized worldwide for his pioneering
contributions in immunoassay technology and diabetes management. He pioneered the use of immunoassay technology
in therapeutic drug monitoring and is often credited for conceiving of the first “personal glucose monitor”, a
consumer device that revolutionized the management of diabetes and created an $8+ billion world wide business. Contact
Gary at: ghstroy@aursos.com
Ronald J. Shebuski, Ph.D – Chief Scientific Officer
Ron has over
20 years experience in the pharmaceutical industry and served as the Director of Cardiovascular Therapeutics at Pharmacia
& Upjohn from 1990-1998. Most recently, he served as the VP of Pre-Clinical Research for Afmedica, Inc, a Kalamazoo,
MI-based biotech start-up that developed a drug-eluting (sirolimus) polymer product which was placed around surgical graft
sites to prevent hemodialysis access and peripheral vascular graft failure. Afmedica was acquired by Angiotech Pharmaceuticals
in late 2005. Ron received his B.S. Degree in Microbiology from the University of Wisconsin in Madison (1976)
and Ph.D. Degree in Pharmacology from the University of Minnesota Medical School in Minneapolis (1985). Contact Ron at : ron@aursos.com
Terry Lewis – Chief Financial Officer
Terry has 30 years financial experience in the pharmaceutical
industry. Most recently, he served as Finance Manger, Michigan Research Services for Pfizer, Inc. Prior
to Pfizer, he held financial director and manager roles at Pharmacia, Inc. in information technology, royalty and licensing,
facilities, cost accounting and corporate systems organizations. Terry has a Bachelor of Business
Administration in Accounting degree from Western
Michigan University. Contact Terry at: terry@aursos.com
